21418547|t|Selectivity to amyloid-beta precursor protein cleavage provides hope against Alzheimer's.
21418547|a|Toward development of a safe and effective treatment for Alzheimer's disease, Elan Pharmaceuticals reported a novel gamma-secretase inhibitor that specifically targets the cleavage of amyloid-beta precursor protein, opening the way to design of substrate-specific gamma-secretase inhibitors that would reduce the amyloid burden without significant adverse events.
21418547	15	45	amyloid-beta precursor protein	Gene	351
21418547	77	88	Alzheimer's	Disease	MESH:D000544
21418547	147	166	Alzheimer's disease	Disease	MESH:D000544
21418547	274	304	amyloid-beta precursor protein	Gene	351
21418547	403	410	amyloid	Disease	MESH:C000718787
21418547	Association	MESH:D000544	351

